daratumumab,talquetamab,teclistamab,pomalidomide
janssen,genmab
['trimm-2', 'multiple myeloma', 'mmsm', 'thank you']
huge thank you to of for dropping by to discuss updated results from the trimm-2 study in relapsed/refractory multiple myeloma! as always, check out our website for more updates and information from #asco23! #mmsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.